Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008–2016

Patients with metastatic breast cancer (MBC) often require inpatient palliative care (IPC). However, mounting evidence suggests age-related disparities in palliative care delivery. This study aimed to assess the cumulative incidence function (CIF) of IPC delivery, as well as the influence of age. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2020-09, Vol.137, p.240-249
Hauptverfasser: Frasca, Matthieu, Sabathe, Camille, Delaloge, Suzette, Galvin, Angeline, Patsouris, Anne, Levy, Christelle, Mouret-Reynier, Marie A., Desmoulins, Isabelle, Vanlemmens, Laurence, Bachelot, Thomas, Goncalves, Anthony, Perotin, Virginie, Uwer, Lionel, Frenel, Jean S., Ferrero, Jean M., Bouleuc, Carole, Eymard, Jean C., Dieras, Véronique, Leheurteur, Marianne, Petit, Thierry, Dalenc, Florence, Jaffre, Anne, Chevrot, Michaël, Courtinard, Coralie, Mathoulin-Pelissier, Simone
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patients with metastatic breast cancer (MBC) often require inpatient palliative care (IPC). However, mounting evidence suggests age-related disparities in palliative care delivery. This study aimed to assess the cumulative incidence function (CIF) of IPC delivery, as well as the influence of age. The national ESME (Epidemio-Strategy-Medical-Economical)-MBC cohort includes consecutive MBC patients treated in 18 French Comprehensive Cancer Centres. ICD-10 palliative care coding was used for IPC identification. Our analysis included 12,375 patients, 5093 (41.2%) of whom were aged 65 or over. The median follow-up was 41.5 months (95% confidence interval [CI], 40.5–42.5). The CIF of IPC was 10.3% (95% CI, 10.2–10.4) and 24.8% (95% CI, 24.7–24.8) at 2 and 8 years, respectively. At 2 years, among triple-negative patients, young patients (
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2020.07.007